Ranjana Advani is an Oncology physician affiliated with Stanford Medicine. OpenAlex indexes 835 publications with 48,230 citations (h-index 101); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 12 Apr 2024.
Clinical trials
- Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma
Sponsor: Ranjana Advani
- Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
Sponsor: Associazione Angela Serra per la ricerca sul cancro
- Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Sponsor: ECOG-ACRIN Cancer Research Group
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20254 payments
- Merck Sharp & Dohme LLCProgram year20252 payments
- F. Hoffmann-La Roche AGProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
New England Journal of Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Weisman, MD
Stanford Medicine
Maurice Ohayon, MD, DSC, PhD
Stanford Medicine
Bruno Medeiros, MD
Stanford Medicine
Michael Khodadoust, MD/PHD
Stanford Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”